420mg Sigrima Pertuzumab Injection

Name: 420mg Sigrima Pertuzumab Injection
Brand: Amari Trade Alliance LLP
Price: 56000 INR
Availability: InStock

Price 56000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

420mg Sigrima Pertuzumab Injection Specification

Dosage Form
Injection

Brand Name
Sigrima

Packaging Type
Vial

Origin of Medicine
India

Life Span
2 Years

Salt Composition
Pertuzumab

Drug Type
Biological

Ingredients
Pertuzumab

Physical Form
Injection

Quantity
1 Vial

Single use only
Yes

Anticancer agent
Yes

Prescription only
Yes

Clear solution
Yes

For IV infusion
Yes

Export quality
Yes

Strength
420 mg

420mg Sigrima Pertuzumab Injection Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
10 Vials Per Week

Delivery Time
7 Days

About 420mg Sigrima Pertuzumab Injection

Unlock optimum care with Sigrima Pertuzumab Injection 420mg, a transcendent anticancer agent designed for the modern medical landscape. Ideal for IV infusion and strictly single-use, this radiant clear solution ensures remarkable efficacy with a dosage strength of 420mg per vial. Manufactured with export-quality assurance in India, each prescription-only vial embodies exceptional reliability for cancer therapy. Benefit from a 2-year lifespan and safe delivery in vial packaging. Get it now at a great bargain-buy online from the leading exporter, supplier, and trader for assured quality and prompt service.

Advanced Usage & Application for Precise Cancer Care

420mg Sigrima Pertuzumab Injection is meticulously designed for hospital and clinical usage. Dedicated to intravenous (IV) infusion, it specifically targets cancer cell pathways, facilitating targeted therapy as prescribed by qualified oncologists. The application medium is a clear, ready-to-use injectable solution, ideal for single-use administration. Its robust formulation and strict usage protocols ensure optimal therapeutic impact while adhering to international standards, making it a trustworthy option in oncological treatment regimens.

Sample Policy & Packaging Excellence for Quick Acquisition

Customers interested in evaluating 420mg Sigrima Pertuzumab Injection can benefit from a straightforward sample policy. Sample vials are available upon purchase order, supporting exchange requirements and quality assurance reviews. Each vial is securely packaged to preserve integrity and facilitate swift, damage-free delivery. With quick dispatch mechanisms in place, clients can expect efficient order processing and prompt receipt of their sample or full stock, enhancing confidence in product procurement and long-term partnerships.

FAQ's of 420mg Sigrima Pertuzumab Injection:

Q: How should Sigrima Pertuzumab Injection 420mg be administered?

A: This injection is administered via intravenous (IV) infusion by a healthcare professional in a clinical or hospital setting, ensuring precise dosage and therapeutic effect.

Q: What conditions is Sigrima Pertuzumab Injection typically prescribed for?

A: It is primarily used as an anticancer biological agent for targeted cancer therapy, specifically prescribed by oncologists for certain types of cancer as part of a combination treatment.

Q: When is a purchase order required for obtaining a sample vial?

A: A purchase order is necessary when requesting a sample vial to ensure secure transaction processing and facilitate orderly exchange and delivery mechanisms.

Q: Where is Sigrima Pertuzumab Injection manufactured and exported from?

A: This product is manufactured and exported from India, ensuring export-quality standards and global accessibility for healthcare facilities and professionals.

Q: What is the process for storing and handling the injection before use?

A: The vial should be stored at temperatures specified by the manufacturer and not used beyond its 2-year shelf life. Handling should follow strict medical protocols to maintain product integrity.

Q: What are the primary benefits of using a clear, single-use vial?

A: A single-use, clear vial minimizes the risk of contamination, ensures correct dosage, and guarantees sterility, which is essential for optimal patient safety during cancer treatment.

Tell us about your requirement